He only won one board seat so I don't know how much of a difference that will make...
(Reuters) - Billionaire investor Carl Icahn appears to have secured one of the four board seats he sought at drugmaker Forest Laboratories Inc (FRX.N), according to an early tally of shareholder votes at the company's annual meeting on Wednesday.
Forest said Icahn nominee Pierre Legault, a former executive at several big drugmakers, was likely to win a seat on the 10-member board following a bitter proxy battle. He would replace current director Dan Goldwasser, who chairs the compensation committee.
"Shareholders are sending the message loud and clear that they're fed up," Daniel Ninivaggi, one of the Icahn nominees, said at the Forest meeting in New York.